These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33639198)

  • 1. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
    Hachem M
    Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
    Erickson MA; Rhea EM; Knopp RC; Banks WA
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
    Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
    Front Immunol; 2021; 12():697329. PubMed ID: 34386007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.
    Welcome MO; Mastorakis NE
    Inflammopharmacology; 2021 Aug; 29(4):939-963. PubMed ID: 33822324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection.
    Alquisiras-Burgos I; Peralta-Arrieta I; Alonso-Palomares LA; Zacapala-Gómez AE; Salmerón-Bárcenas EG; Aguilera P
    Mol Neurobiol; 2021 Feb; 58(2):520-535. PubMed ID: 32978729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
    Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B
    Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
    Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
    FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
    Alam SB; Willows S; Kulka M; Sandhu JK
    Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
    Romero A; Ramos E; López-Muñoz F; Gil-Martín E; Escames G; Reiter RJ
    Cell Mol Neurobiol; 2022 Apr; 42(3):489-500. PubMed ID: 32772307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Symptoms of COVID-19: The Zonulin Hypothesis.
    Llorens S; Nava E; Muñoz-López M; Sánchez-Larsen Á; Segura T
    Front Immunol; 2021; 12():665300. PubMed ID: 33981312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 invasion of the central nervous: a brief review.
    Siddiqui R; Mungroo MR; Khan NA
    Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.